KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Non-Current Deffered Revenue (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Non-Current Deffered Revenue for 9 consecutive years, with $249000.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 6.74% to $249000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $249000.0 through Dec 2025, down 6.74% year-over-year, with the annual reading at $249000.0 for FY2025, 6.74% down from the prior year.
  • Non-Current Deffered Revenue hit $249000.0 in Q4 2025 for Bionano Genomics, up from $192000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $292000.0 in Q1 2025 to a low of $108000.0 in Q1 2021.
  • Historically, Non-Current Deffered Revenue has averaged $191250.0 across 5 years, with a median of $189000.0 in 2023.
  • Biggest five-year swings in Non-Current Deffered Revenue: skyrocketed 153.57% in 2021 and later dropped 28.87% in 2024.
  • Year by year, Non-Current Deffered Revenue stood at $146000.0 in 2021, then fell by 13.01% to $127000.0 in 2022, then grew by 21.26% to $154000.0 in 2023, then soared by 73.38% to $267000.0 in 2024, then dropped by 6.74% to $249000.0 in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for BNGO at $249000.0 in Q4 2025, $192000.0 in Q3 2025, and $243000.0 in Q2 2025.